RNA (Avidity Biosciences Inc) Earnings per share for the trailing year
The annual EPS growth rate over the last 12 months demonstrates how market quotes react to the elite status of the RNA therapy developers, where patents protect the business from tech giants. Avidity Biosciences (RNA) saw this metric reach 0.00, confirming the success of its unique drug delivery system to muscles. Meanwhile, Avidity Biosciences (RNA) strictly adheres to bio-waste disposal standards, minimizing its environmental impact.
%20Avidity%20Corp&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_RNA_-_Avidity-Biosciences_-_Net-earnings-per-share-EPS-TTM "RNA (Avidity Corp) Earnings per share for the last twelve months history from 02/11/2024 to 11/14/2026 | 👁️GURU.Markets👁️")
RNA (Avidity): analytical breakdowns and indicator data
- price and consensus price forecast:
- business market valuation indicators:
- issuer book value statistics:
- company total debt and liquidity indicators:
Debt to Capital Avidity Biosciences|RNA - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Avidity Corp|RNA - Company Aggregate Debts|Debt to Book Value Avidity Biosciences Inc|RNA - Company Long-Term Debts|Short-Term Debt Volume Avidity Biosciences|Immediate Liquidity aviditybiosciences.com
- earnings and valuation multiples indicators:
RNA - Company Net Income|Net Profit Forecast Avidity Biosciences|RNA - P/E Multiple|Projected Price to Earnings Avidity Biosciences Inc|RNA - PEG Multiple|Company Value to EBITDA Avidity Biosciences Inc|RNA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Avidity Biosciences|RNA - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months aviditybiosciences.com|RNA - Earnings per share growth in current year|Projected earnings per share growth rate for next year Avidity Biosciences
- sales and revenue indicators:
Fundamental company valuation:Avidity Biosciences
Investors are assessing the resilience of Avidity Biosciences (RNA) through net earnings per share dynamics, which measure the annual growth rate of equity value by smoothing out quarterly fluctuations. By analyzing the history of EPS YoY (TTM) percentage changes, one can correlate financial performance with advancements in AOC therapy development and R&D cost control, allowing for a determination of the business's actual expansion stage.
Competitor analysis for Avidity Biosciences
Net earnings per one share for the last twelve months Tempus AI, Inc.|QGEN (Qiagen) - Net earnings per share for the last 12 months|Ionis Pharmaceuticals, Inc. - Earnings per share for the trailing year|RGEN (Repligen Corp.) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months CRSP|Net earnings per share (EPS TTM) WGS|Net earnings per share for the last four quarters ultragenyx.com|Earnings per share for the last twelve months Beam Therapeutics BEAM|Sarepta Therapeutics (SRPT) - Net earnings per one share for the last twelve months|TWST - Earnings per share for the last twelve months|Net earnings per share for the last four quarters 10x TXG|NTLA: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months stoketherapeutics.com|BLFS (BioLife Solutions) - Net earnings per share (EPS TTM)|Wave Life Sciences Ltd (WVE) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) MAZE|SION - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Prime Medicine, Inc. PRME|TSHA: Earnings per share for the last 12 months|uniQure - Net earnings per share (EPS TTM)|MeiraGTx Holdings (MGTX) - Net earnings per share for the last 12 months|RGNX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Solid Corp (SLDB)|Earnings per share for the last twelve months Ocugen, Inc.|pacb.com (PACB) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Benitec Biopharma (BNTC)|DSGN (Design Therapeutics Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Rocket Pharmaceuticals Inc RCKT|FDMT: Earnings per share for the last 12 months|Lexeo - Net earnings per share (EPS TTM)|KRRO - Net earnings per share (EPS TTM)|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|Earnings per share for the last twelve months ProQR|Earnings per share for the last 12 months CDXS (Codexis Bio)|Net earnings per share (EPS TTM) SGMO|Net earnings per share (EPS TTM) nautilus.bio (NAUT)|Net earnings per share (EPS TTM) MGX (Metagenomi)|Net earnings per share (EPS TTM) Precision BioSciences Inc. DTIL|GBIO: Net earnings per share for the last 12 months|BOLD: Earnings per share for the last twelve months|XCUR: Net earnings per share (EPS TTM)|IMNN - Net earnings per share for the last four quarters|PHIO (Phio Pharmaceuticals Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months MBIO (Mustang Bio Corp)|Net earnings per share (EPS TTM) RNAZ|Net earnings per share for the last four quarters bionanogenomics.com|Applied DNA Sciences - Net earnings per share for the last 12 months|Earnings per share for the last four quarters BLUE (bluebirdbio.com)|IPA: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Omega Therapeutics Inc|OMIC (Singular Genomics Systems Inc) - Net earnings per share for the last 12 months|Regulus - Earnings per share for the trailing year|SYRS (Syros Pharmaceuticals) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months TBIO|Net earnings per share (EPS TTM) TCON|Net earnings per share for the last four quarters Unity Biotechnology Inc.
